Cytek Biosciences, Inc. CTKB
5.70 USD -0.14 (-2.40%)
As ofNov 16, 2026, 10:21 AM EST
5.65 Day range 5.83
3.31 52-week range 6.34
- YTD
- +12.87%
- 1 year
- +3.64%
News
benzinga.com Stephens & Co. Maintains Overweight on Cytek Biosciences, Raises Price Target to $7 Stephens & Co. analyst Mason Carrico maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and raises the price target from $6 to $7.
benzinga.com Cytek Biosciences Q3 2026 Earnings Call Transcript Cytek Biosciences (NASDAQ:CTKB) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Cytek Biosciences Q3 EPS $(0.05) Beats $(0.08) Estimate, Sales $53.229M Beat $52.800M Estimate Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 25 percent decrease over losses of…
benzinga.com Cytek Biosciences Narrows FY2026 Sales Guidance from $207.000M-$212.000M to $208.000M-$211.000M vs $209.415M Est Cytek Biosciences (NASDAQ:CTKB) narrows FY2026 sales outlook from $207.000 million-$212.000 million to $208.000 million-$211.000 million vs $209.415 million estimate.
